These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
111 results:

  • 1. Performing [
    Borgwardt L; Brok J; Andersen KF; Madsen J; Gillings N; Fosbøl MØ; Denholt CL; Petersen IN; Sørensen LS; Enevoldsen LH; Oturai PS; Johannesen HH; Højgaard L; Schulze C; Saxtoft E; Andersen F; Fischer BM
    J Nucl Med; 2024 Aug; 65(8):1286-1292. PubMed ID: 38960713
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of Social Vulnerabilities of Care and Prognosis in Adult Ocular Melanomas in the US.
    Mensah JA; Fei-Zhang DJ; Rossen JL; Rahmani B; Bentrem DJ; Stein JD; French DD
    Ann Surg Oncol; 2024 May; 31(5):3302-3313. PubMed ID: 38418655
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined visual and quantitative assessment of somatostatin receptor scintigraphy for staging and restaging of neuroendocrine tumors.
    Ueki Y; Otsuka H; Otani T; Kasai R; Otomi Y; Ikemitsu D; Azane S; Kunikane Y; Bando T; Matsuda N; Okada Y; Takayama T; Harada M
    Jpn J Radiol; 2024 May; 42(5):519-535. PubMed ID: 38345724
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
    Bender HG; Irwin MS; Hogarty MD; Castleberry R; Maris JM; Kao PC; Zhang FF; Naranjo A; Cohn SL; London WB
    J Clin Oncol; 2023 Jun; 41(17):3149-3159. PubMed ID: 37098238
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Routine imaging guided by a 31-gene expression profile assay results in earlier detection of melanoma with decreased metastatic tumor burden compared to patients without surveillance imaging studies.
    Dhillon S; Duarte-Bateman D; Fowler G; Hagstrom MNE; Lampley N; Olivares S; Fumero-Velázquez MS; Vu K; Wayne JD; Gastman BR; Vetto J; Gerami P
    Arch Dermatol Res; 2023 Oct; 315(8):2295-2302. PubMed ID: 36977840
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and Prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report.
    Pinto N; Naranjo A; Ding X; Zhang FF; Hibbitts E; Kennedy R; Tibbetts R; Wong-Michalak S; Craig DW; Manojlovic Z; Hogarty MD; Kreissman S; Bagatell R; Irwin MS; Park JR; Asgharzadeh S
    Clin Cancer Res; 2023 Apr; 29(8):1546-1556. PubMed ID: 36749880
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma.
    Jones S; Henry V; Strong E; Sheriff SA; Wanat K; Kasprzak J; Clark M; Shukla M; Zenga J; Stadler M; Dzwierzynski W; Harker-Murray A; Young K; Kothari AN; Clarke CN
    J Surg Res; 2023 Jun; 286():35-40. PubMed ID: 36739830
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Maracci ME; Sirolli M; Orsatti A; Chiarucci F; Franchini E; Borsato M; Massari F; Mollica V; Bianchi FM; Colecchia M; Acosta AM; Fiorentino M
    Pathol Res Pract; 2023 Feb; 242():154337. PubMed ID: 36706585
    [TBL] [Abstract] [Full Text] [Related]  

  • 10.
    Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
    Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [
    Samim A; Blom T; Poot AJ; Windhorst AD; Fiocco M; Tolboom N; Braat AJAT; Viol SLM; van Rooij R; van Noesel MM; Lam MGEH; Tytgat GAM; de Keizer B
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1146-1157. PubMed ID: 36504277
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of 68 Ga-FAPI-04 PET/CT on staging and Therapeutic Management in Patients With Digestive System tumors.
    Kosmala A; Serfling SE; Schlötelburg W; Lindner T; Michalski K; Schirbel A; Higuchi T; Hartrampf PE; Buck AK; Weich A; Werner RA
    Clin Nucl Med; 2023 Jan; 48(1):35-42. PubMed ID: 36354691
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance.
    McMahon S; Zhou X; Baggett CD; Bjurlin MA; Chen RC; Riggs SB; Litwin MS; Milowsky MI; Wallen EM; Tan HJ
    Clin Genitourin Cancer; 2022 Aug; 20(4):307-318. PubMed ID: 35581139
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immune-Related Adverse Events After Immune Checkpoint Inhibitors for Melanoma Among Older Adults.
    Schonfeld SJ; Tucker MA; Engels EA; Dores GM; Sampson JN; Shiels MS; Chanock SJ; Morton LM
    JAMA Netw Open; 2022 Mar; 5(3):e223461. PubMed ID: 35315916
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.
    Irwin MS; Naranjo A; Zhang FF; Cohn SL; London WB; Gastier-Foster JM; Ramirez NC; Pfau R; Reshmi S; Wagner E; Nuchtern J; Asgharzadeh S; Shimada H; Maris JM; Bagatell R; Park JR; Hogarty MD
    J Clin Oncol; 2021 Oct; 39(29):3229-3241. PubMed ID: 34319759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.
    El Sharouni MA; Ahmed T; Varey AHR; Elias SG; Witkamp AJ; Sigurdsson V; Suijkerbuijk KPM; van Diest PJ; Scolyer RA; van Gils CH; Thompson JF; Blokx WAM; Lo SN
    J Clin Oncol; 2021 Apr; 39(11):1243-1252. PubMed ID: 33600211
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma.
    Rantala ES; Kivelä TT; Hernberg MM
    Melanoma Res; 2021 Jun; 31(3):224-231. PubMed ID: 33595243
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study.
    Ebbehoj A; Li D; Kaur RJ; Zhang C; Singh S; Li T; Atkinson E; Achenbach S; Khosla S; Arlt W; Young WF; Rocca WA; Bancos I
    Lancet Diabetes Endocrinol; 2020 Nov; 8(11):894-902. PubMed ID: 33065059
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
    Hieken TJ; Glasgow AE; Enninga EAL; Kottschade LA; Dronca RS; Markovic SN; Block MS; Habermann EB
    J Womens Health (Larchmt); 2020 Sep; 29(9):1160-1167. PubMed ID: 32105561
    [No Abstract]    [Full Text] [Related]  

  • 20. Internal Pathology Review of Invasive Melanoma: An Academic Institution Experience.
    Isom C; Hooks M; Kauffmann RM
    J Surg Res; 2020 Jun; 250():97-101. PubMed ID: 32044512
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.